| 489398 |
BMJ OPEN |
Moving 2 Mindful (M2M) study protocol: testing a mindfulness group plus ecological momentary intervention to decrease stress and anxiety in adolescents from high-conflict homes with a mixed-method longitudinal design |
2019-11-01 |
10.1136/bmjopen-2019-030948 |
Lucas-Thompson Rachel, Seiter Natasha, Broderick Patricia C, Coatsworth James Douglas, Henry Kimberly L, McKernan Charlotte J, Smyth Joshua M |
| 489397 |
BMJ OPEN |
Medication errors during simulated paediatric resuscitations: a prospective, observational human reliability analysis |
2019-11-01 |
10.1136/bmjopen-2019-032686 |
Appelbaum Nicholas, Clarke Jonathan, Feather Calandra, Franklin Bryony, Sinha Ruchi, Pratt Phillip, Maconochie Ian, Darzi Ara |
| 489396 |
BIOMOLECULES & THERAPEUTICS |
Role of Helix 8 in Dopamine Receptor Signaling |
2019-11-01 |
10.4062/biomolther.2019.026 |
Yang, Han-Sol, Sun, Ningning, Zhao, Xiaodi, Kim, Hee Ryung, Park, Hyun-Ju, Kim, Kyeong-Man, Chung, Ka Young |
| 489395 |
ONCOTARGETS AND THERAPY |
FGFR1 Induces Acquired Resistance Against Gefitinib By Activating AKT/mTOR Pathway In NSCLC |
2019-11-01 |
10.2147/ott.s220462 |
Zhang Dan, Han Li-li, Du Fen, Liu Xiao-meng, Li Jin, Wang Hui-hui, Song Ming-hui, Li Zeng, Li Guo-yin |
| 489394 |
AMERICAN JOURNAL OF KIDNEY DISEASES : THE OFFICIAL JOURNAL OF THE NATIONAL KIDNEY FOUNDATION |
Characteristics Associated With Peritoneal Dialysis Technique Failure: Are We Asking the Right Questions? |
2019-11-01 |
10.1053/j.ajkd.2019.07.002 |
Nadeau-Fredette Annie-Claire, Bargman Joanne M. |
| 489393 |
NEURO-ONCOLOGY |
NIMG-37. PREDICTING SEIZURE IN GLIOMA PATIENTS USING A RANDOM FOREST CLASSIFIER TRAINED ON SEX-SPECIFIC AND MIXED COHORTS |
2019-11-01 |
10.1093/neuonc/noz175.707 |
Khurana Aditya, Johnston Sandra, Whitmire Paula, Ranjbar Sara, Sharma Akanksha, Hawkins-Daarud Andrea, Rubin Joshua, Porter Alyx, Canoll Peter D, Egan Kathleen, Hu Leland, Mrugula Maciej, Kumthekar Priya, Swanson Kristin |
| 489392 |
NEURO-ONCOLOGY |
EXTH-07. OPTIMIZATION OF TARGETING ELTD1 IN GLIOBLASTOMA USING A MOLECULAR TARGETING APPROACH | EXTH-07. OPTIMIZATION OF TARGETING ELTD1 IN GLIOBLASTOMA USING A MOLECULAR TARGETING APPROACH |
2019-11-01 |
10.1093/neuonc/noz175.341 |
Smith Nataliya, Sauders Debra, Towner Rheal, Zalles Michelle |
| 489391 |
NEURO-ONCOLOGY |
GENE-59. NOT ALL p53 MUTATIONS ARE CREATED EQUAL: A MURINE ASTROCYTE MODEL FOR HIGH-THROUGHPUT FUNCTIONAL ASSESSMENT OF p53 MISSENSE MUTATIONS | GENE-59. NOT ALL p53 MUTATIONS ARE CREATED EQUAL: A MURINE ASTROCYTE MODEL FOR HIGH-THROUGHPUT FUNCTIONAL ASSE |
2019-11-01 |
10.1093/neuonc/noz175.461 |
Rockwell Nathan, Staller Max, Cannella Maria, Cohen Barak, Rubin Joshua |
| 489390 |
NEURO-ONCOLOGY |
IMMU-40. CANCER IMMUNOEDITING SHAPES THE IMMUNE ESCAPE SIGNATURE AND CLONAL ARCHITECTURE IN GLIOMAS | IMMU-40. CANCER IMMUNOEDITING SHAPES THE IMMUNE ESCAPE SIGNATURE AND CLONAL ARCHITECTURE IN GLIOMAS |
2019-11-01 |
10.1093/neuonc/noz175.532 |
Lamszus Katrin, Mohme Malte, Maire Cecile, Riecken Kristoffer, Alawi Malik, Fehse Boris, Westphal Manfred |
| 489389 |
NEURO-ONCOLOGY |
EPID-17. ANALYSIS OF THE USE OF BEVACIZUMAB FOR THE TREATMENT OF GLIOBLASTOMA IN THE UNITED STATES |
2019-11-01 |
10.1093/neuonc/noz175.317 |
Garcia Catherine, Chitwood Holly, Harwood Christopher, Shelton Brent, Morgan Rachael, Vermuelen Lee, Villano John |
